Rinvoq 45 mg prompts ‘rapid resolution’ of Crohn’s disease symptoms as early as day 5
Once-daily Rinvoq 45 mg provided “rapid relief” of stool frequency and abdominal pain score within the first week of induction therapy in patients with moderately to severely active Crohn’s disease, according to a data analysis. “In the U-EXCEL and U-EXCEED induction trials, upadacitinib 45 mg taken once daily demonstrated significantly greater efficacy vs. placebo